Global Antihyperlipidemic Drugs Market Is Estimated To Witness High...

added article Health

2023-10-09 13:09:44 -

Global Antihyperlipidemic Drugs Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Cardiovascular Diseases

The Antihyperlipidemic Drugs Market is estimated to be valued at US$ 12.6 Bn in 2022 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview: Antihyperlipidemic drugs are used to lower and control the levels of lipids, such as cholesterol and triglycerides, in the blood. These drugs are...

0 Comments 0 Shares 871 Views 0 Reviews